Conroy T, Malissard L, Dartois D, Luporsi E, Stines J, Chardot C
Service de médecine, Centre Alexis-Vautrin, Brabois, Vandoeuvre-les-Nancy, France.
Bull Cancer. 1988;75(9):845-57.
The records of 429 patients seen at the Centre Alexis-Vautrin in 1979 and 1980 with bony metastases were retrospectively reviewed to assess their natural history and survival. Breast was the location of primary lesion in 140 patients (32.6%), lung in 95 patients (22.1%) and prostate in 33 patients (7.7%). The primary tumor was of unknown origin in 42 cases (10.9%). The median survival from time of diagnosis was 5 months. Two and 5-year survival rates were 17.5 and 5.1% respectively. According to the nature of the primary tumor, 2 and 5-year survival periods for bony metastases were 36.4 and 7.9% in breast cancer, 33.3 and 15.2% in prostatic cancer, 4.3 and 2.1% in metastases of unknown origin, 2.1 and 0% in pulmonary carcinoma. Multivariate analysis revealed four factors to be of prognostic significance for survival: the nature of the primary tumor, the absence of local relapse, the disease-free interval and the absence of metastases in other sites. Patients with hormone-sensitive lesions or slowly-growing tumors had a better prognosis.
对1979年和1980年在阿列克西 - 沃特兰中心就诊的429例有骨转移的患者记录进行回顾性分析,以评估其自然病史和生存情况。140例患者(32.6%)原发灶位于乳腺,95例患者(22.1%)位于肺,33例患者(7.7%)位于前列腺。42例患者(10.9%)原发肿瘤来源不明。从诊断时起的中位生存期为5个月。2年和5年生存率分别为17.5%和5.1%。根据原发肿瘤的性质,骨转移患者的2年和5年生存期在乳腺癌中分别为36.4%和7.9%,前列腺癌中分别为33.3%和15.2%,来源不明的转移中分别为4.3%和2.1%,肺癌中分别为2.1%和0%。多因素分析显示有四个因素对生存具有预后意义:原发肿瘤的性质、无局部复发、无病间期以及其他部位无转移。激素敏感病变或生长缓慢肿瘤的患者预后较好。